MindMed stock has spiked higher by over 30%, on big volume. New investor focus on the deepest clinical research program in the industry.
Articles
Revive Therapeutics Provides Corporate Update on its Psychedelics Therapeutics Programs
Revive's corporate update centers on psilocybin research on a new delivery system and addiction treatment.
Texas Ban On Smokable Hemp Lifted Until 2021, Judge Rules
A Texas ban on smokable hemp products hit another roadblock in court last week when a state judge barred officials from enforcing the prohibition until an industry challenge can be heard in court.
New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce
A coalition of advocacy groups and marijuana businesses have unveiled a unique plan to legalize interstate cannabis commerce regardless of ongoing federal prohibition.
Nebraska Activists Submit 15k Signatures to Establish ‘Legal Marijuana Now’ Party
Nebraska activists have turned in 15,000 signatures to establish the Legal Marijuana Now party in the state, four years after falling short due to a lack of valid signatures, the Lincoln Journal-Star reports.
MindMed Submits Application For NASDAQ Up-Listing, Appoints Canaccord Genuity As Financial Advisor
MindMed Inc has applied to up-list on the NASDAQ.
Survey Shows Support For Marijuana Legalization Among South Dakota Voters
Could marijuana legalization be on its way to South Dakota? As if 2020 couldn’t get any stranger, a new poll suggests that voters in the Mount Rushmore State could be ready to take the leap.
Numinus Announces Listing of Warrants
Numinus warrants have an exercise price of CAD$0.35 and are valid until September 10, 2022.
Mind Cure Targets Multi-Billion Dollar Sweet-Spot in Life Sciences
The road to psychedelic drug success leads through functional mushrooms.
Cannabis-based packaging and paper could reduce waste, promote sustainability
Cannabis businesses have long struggled with the excessive packaging their products are required to use, employing extra layers of plastic and paper to ensure that flower or vape products are childproof and don’t fall into the wrong hands.
Why Canada Is The Natural Launch-Pad For The Psychedelic Drug Industry
Canada stands out as the premier destination for psychedelic drug companies.
Study: Cannabis Effective for Treating Chemotherapy Side Effects
A study by researchers at Australia’s Chris O’Brien Lifehouse found a 14-25 percent reduction in chemotherapy side effects, such as nausea and vomiting, in patients who used cannabis capsules containing a 1:1 THC to CBD ratio, 9News reports.
Compass’s Upsized IPO Financing Sends ‘Buy’ Signal For Sector
Compass has boosted its IPO financing by roughly 20% AND increased the unit price -- signalling strong interest in the psychedelic space.
Stakeholders React to Medical Marijuana Research Act Moving to House Floor
Industry stakeholders by and large support the House Committee on Energy and Commerce passing on a voice vote a modified version of the Medical Marijuana Research Act of 2019.